After 27 years of development, 16 successful university clinical trials, and over 53 publications the FDA approved Microdose Insulin Infusion (MII) treatment has proven that it slows, halts, and/or reverses, in most cases, the chronic complications associated with type I and II diabetes.
With over 200,000 treatments at domestic and international locations, with no adverse events, MII reveals amazing results by treating the core problem of diabetes through restoring proper carbohydrate metabolism.
Hear it first hand in the following patient testimonials...
We have a lot of data, in fact we have over 53 publications. To save you some time here’s a couple of them to get you started.
- Study Validates How ... Reduce Hospitalization Rates/Costs and Reverse Neuropathy
- Artificial Pancreas Treatment® Performance Chart
- Impaired glucose tolerance and type 2 diabetes
- Chronic Intermittent Intravenous Insulin Therapy: A New Frontier in Diabetes Therapy
Interested in learning more? Contact us, we’d love to take care of your needs.